Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Operating Officer

Chief Medical Officer

Chief Patient Supply Officer

Chief Commercial Officer

Chief Financial Officer

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; co-development collaboration agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in th...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer
2024-01-11	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-11	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-11	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-11	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer
2023-09-01	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-08-01	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer
2023-07-10	Premium	sold	Premium	Premium	Premium	-
2023-06-27	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-06-01	Premium	acquired	Premium	Premium	Premium	-
2023-06-01	Premium	acquired	Premium	Premium	Premium	-
2023-01-31	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-01-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-01-17	Premium	sold	Premium	Premium	Premium	Chief Patient Supply Officer

ADAP - Adaptimmune Therapeutics Plc Stock Price, Fair Value and News

Latest Insider Trading transactions for ADAP